MYO1E and non-small cell lung carcinoma: MYO1E RNA expression groups only showed differences in stages, showing that the low MYO1E RNA expression group had a higher percentage of patients with NSCLC stage I group and the high MYO1E RNA expression group, a higher proportion of patients with NSCLC stage II (p = 0.036).